[Characteristic of metformin for treatment of impaired glucose tolerance].
Ishida
Wataru
W
Department of Diabetes and Metabolism, Iwate Medical University.
Satoh
Jo
J
D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control; D001645:Biguanides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000517:prevention & control*; D005947:Glucose / Q000378:metabolism; D018149:Glucose Intolerance / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007333:Insulin Resistance; D050356:Lipid Metabolism; D008687:Metformin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D001645:Biguanides; D007004:Hypoglycemic Agents; D008687:Metformin; D005947:Glucose